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The inherited palmoplantar keratodermas (PPKs) are a heterogeneous group of
genodermatoses, characterized by thickening of the epidermis of the palms and
soles. No classification system satisfactorily unites clinical presentation, pathology
and molecular pathogenesis. There are four patterns of hyperkeratosis – striate,
focal, diffuse and punctate. Mutations in the desmoglein 1 gene (DSG1), a trans-
membrane glycoprotein, have been reported primarily in striate, but also in focal
and diffuse PPKs. We report seven unrelated pedigrees with dominantly inherited
PPK owing to mutations in the DSG1 gene, with marked phenotypic variation.
Genomic DNA from each family was isolated, and individual exons amplified by
polymerase chain reaction. Sanger sequencing was employed to identify mutations.
Mutation analysis identified novel mutations in five families (p.Tyr126Hisfs*2,
p.Ser521Tyrfs*2, p.Trp3*, p.Asp591Phefs*9 and p.Met249Ilefs*6) with striate
palmar involvement and varying focal or diffuse plantar disease, and the recurrent
mutation c.76C>T, p.Arg26*, in two families with variable PPK patterns. We
report one recurrent and five novel DSG1 mutations, causing varying patterns of
PPK, highlighting the clinical heterogeneity arising from mutations in this gene.
What’s already known about this topic?
• Twenty-three mutations in the desmoglein 1 gene (DSG1) have been described in
25 families with palmoplantar keratoderma (PPK).
• The majority have striate palmar involvement with focal plantar keratoderma, but
isolated focal and diffuse PPKs have been reported.
What does this study add?
• DSG1 mutations can present with variable phenotype within the same family.
• Environmental factors, such as manual labour, may alter the clinical appearance of
PPK.
• A lower threshold should be considered for DSG1 screening in nonstriate PPK
where an underlying keratin mutation has not been identified.
© 2016 The Authors. British Journal of Dermatology
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The inherited palmoplantar keratodermas (PPKs) are clinically
and genetically heterogeneous genodermatoses, characterized
by epidermal thickening of the palms and soles. Many kerato-
dermas are restricted to these sites, but other cutaneous and
extracutaneous features can occur.1 Traditionally, classification
is based on the pattern of hyperkeratosis, notably diffuse, focal,
striate and punctate. Identification of the genetic basis of these
disorders has resulted in a molecular-based classification;2 how-
ever, no single classification system satisfactorily unites the clin-
ical presentation, pathology and molecular pathogenesis.
Striate PPK (SPPK) is a rare, mainly autosomal dominant dis-
order characterized by linear hyperkeratosis of the volar aspects
of the fingers and sometimes the palms. SPPK is due to defects
in desmosomes, the major epithelial intercellular adhesion junc-
tions, which confer strength and rigidity to tissues that experi-
ence high mechanical stress. The disease displays locus
heterogeneity with causative mutations in four genes – the
desmosomal proteins desmoglein 1 (DSG1) and desmoplakin
(DSP), keratin 1 (KRT1) and keratin 16 (KRT16) having been
reported.3–6
We report one American, one African and five European
unrelated families with autosomal dominant PPK, owing to
one recurrent and five novel DSG1 mutations. These demon-
strate phenotypic variation despite a common molecular basis.
Case reports
Families 1, 2 and 7 presented to their local dermatology ser-
vices. Families 3–6 were identified through the International
Pachyonychia Congenita Research Registry. All reported having
PPK since early childhood, with a positive family history in
pedigrees 1–6. The proband in family 7 was the only known
affected family member. No affected individuals had any his-
tory of skin fragility, blistering, hair or cardiac abnormalities.
In family 1, the proband had striate keratoderma of the dig-
its and palms, with a focal pattern on the soles (Fig. 1a–c).
Her sister and niece had no palmar involvement, but exhibited
isolated focal keratoderma of the soles (Fig. 1d, e). In family
2, the proband and her half-sister had focal palmar and plantar
hyperkeratosis (Fig. 2a, c, d). The proband’s 24-year-old son,
a soldier, had striate hyperkeratosis of the digits, with focal
palmar and plantar involvement (Fig. 2e, f). Mild hyperker-
atosis of the elbows and knees was present in all three indi-
viduals. Families 3–7 had striate patterns on the palms and/or
digits, with focal or diffuse plantar keratoderma (Figs. 2b, 3,
4). Furthermore, the probands in families 3 and 7 had mild
hyperkeratosis over the dorsal interphalangeal joints, and
knuckle (Fig. 4g) and toe pads, respectively. A biopsy of non-











Fig 1. Pedigree, clinical images and mutation
analysis of family 1 (Scottish). (a) Pedigree
showing a history of palmoplantar
keratoderma. The arrow indicates the
proband. (b) Striate hyperkeratosis (arrows)
of the proband’s digits and palm. (c) Soles of
the proband showing focal hyperkeratosis. (d)
Normal palm of the proband’s sister. (e) Soles
of the subject in (d) showing fissuring plantar
hyperkeratosis. (f) DNA sequence of the
desmoglein 1 gene (DSG1) in an unaffected
control sample. (g) The same region of DSG1
from the proband. The arrow indicates the
novel splice-site mutation between exon 5
and intron 5: c.517+5G>C, resulting in a
frameshift and premature stop codon,
p.Tyr126Hisfs*2.
© 2016 The Authors. British Journal of Dermatology
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all patients. Two individuals reported mild plantar pain when
the keratoderma was very thick and unpared, but this was not
a significant feature in the other cases. See Table S1 (see Sup-
porting Information) for a clinical summary.
Blood or saliva was obtained, following written informed
consent and ethical approval by a Western Institutional Review
Board that complies with the Declaration of Helsinki (File S1;
see Supporting Information). Polymerase chain reaction ampli-
fication was performed and Sanger sequencing was employed
to screen the exons and exon/intron boundaries of DSG1,
using primers as previously described.3
Family 1 was screened directly for DSG1 mutations, as the
proband presented with SPPK. Families 2–6 were initially
screened for pachyonychia congenita mutations in keratin
genes KRT6A, KRT6B, KRT6C, KRT16 and KRT17. In family 7,
screening for KRT1 and KRT9, associated with diffuse PPK,
was negative; whole-exome sequencing of the proband and
his unaffected parents was performed (File S1; see Supporting
Information). In all cases, nonpathogenic variants were
excluded through sequencing unaffected family members,
and by reference to the Database of Single Nucleotide Poly-
morphisms, the 1000 Genome Project and the Exome Variant
Server.
Affected members in family 1 had a novel splice-site muta-
tion in DSG1 between exon 5 and intron 5 (c.517+5G>C).
Total RNA was extracted from a skin biopsy, and a cDNA
fragment spanning exons 4–7 was amplified (File S1; see Sup-
porting Information). DNA sequencing revealed very low
levels of expression of the mutant allele, suggesting significant
nonsense-mediated mRNA decay. This mutation leads to skip-
ping of exon 5, resulting in a frameshift and premature stop













Fig 2. Pedigrees of families 2 (Scottish) and 3
(English), clinical images of family 2 and
mutation analysis of families 2 and 3. (a)
Pedigree of family 2 showing a history of
palmoplantar keratoderma. The arrow
indicates the proband. (b) Pedigree of family
3 showing a history of palmoplantar
keratoderma. (c) Palm of the proband’s half-
sister in family 2 showing focal hyperkeratosis
(arrows). (d) Focal plantar hyperkeratosis of
the proband’s forefoot in family 2. (e)
Fingers of the proband’s son in family 2
showing linear hyperkeratosis (arrows) on the
volar surface of the digits with focal palmar
thickening. (f) Soles of the subject in (e)
showing focal plantar hyperkeratosis. (g) DNA
sequence of exon 2 of the desmoglein 1 gene
(DSG1) in an unaffected control sample. (h)
The same region of DSG1 from the probands
of family 2 and 3. The arrow indicates a
heterozygous C>T mutation at c.76 resulting
in a premature termination codon at
p.Arg26*.
© 2016 The Authors. British Journal of Dermatology
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heterozygous for a previously described nonsense mutation in
DSG1 in exon 2 (c.76C>T, p.Arg26*) (Fig. 2g, h).3 Affected
members in family 4 had a novel DSG1 mutation c.1560-
1561del in exon 11, resulting in p.Ser521Tyrfs*2 (Fig. 3c, d).
A novel heterozygous nonsense mutation, c.8G>A resulting in
p.Trp3* in exon 1 (Fig. 3g, h) was found in family 5. Family
6 had a novel mutation, c.1771_1784del14. This 14 base pair
deletion results in p.Asp591Phefs*9 in exon 12 (Fig. 4b, c).
Lastly, the proband in family 7 had a novel DSG1 duplication
mutation, c.746dupT, which results in a frameshift and pre-
mature stop codon, p.Met249Ilefs*6 (Fig. 4h, i).
Discussion
There are three types of SPPK – type 1 (OMIM 148700) is the
most common, caused by mutations in DSG1. SPPK types 2
(OMIM 612908) and 3 (OMIM 607654) are caused by
desmoplakin and keratin-1 mutations, respectively. Desmo-
plakin mutations can be associated with cardiac disease and
woolly hair, but extracutaneous manifestations are not
described with DSG1 mutations. Pachyonychia congenita rarely
presents with striate PPK; Almutawa et al. reported a recurrent













Fig 3. Pedigree, clinical images and mutation
analysis of families 4 (Norwegian) and 5
(Northern Irish). (a) Pedigree of family 4
showing a history of palmoplantar
keratoderma. The arrow indicates the
proband. (b) Striate palmar hyperkeratosis
(arrows) of the proband in family 4. (c) DNA
sequence of exon 11 of the desmoglein 1
gene (DSG1) in an unaffected control sample.
(d) The same region of DSG1 from the
proband in family 4; the arrow indicates a
novel mutation c.1560-1561del resulting in a
frame shift at Ser521Tyrf*2. (e) Pedigree of
family 5. The arrow indicates the proband; no
clinical information was available regarding
her parents. (f) Striate pattern on the digits
with focal palmar hyperkeratosis of the
proband in family 5, who had a focal pattern
on the soles of the feet. (g) DNA sequence of
exon 1 of DSG1 in an unaffected control
sample. (h) The same region of DSG1 from
the proband of family 5. The arrow indicates
a novel mutation c.8G>A, resulting in a
premature termination codon at p.Trp3*.
© 2016 The Authors. British Journal of Dermatology
published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
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keratoderma, nail thickening and knuckle pads.6 Mutations in
other DSG1 binding partners, resulting in varying PPK pheno-
types, have also been described.1 To date, 23 mutations in
DSG1 have been reported in 25 families with PPK; the majority
had striate palmar and focal plantar keratoderma, but focal7 or
diffuse8 palmar patterns have also been described. A more sev-
ere phenotype, severe dermatitis, multiple allergies, and meta-
bolic wasting (SAM) syndrome, has been described in
individuals with biallelic DSG1 mutations9 and in one case
with a heterozygous mutation in desmoplakin.10
We report the largest series of DSG1 mutations to date; two
nonsense mutations (c.76C>T; p.Arg26* and c.8G>A;
p.Trp3*), one duplication (c.746dupT; p.Met249Ilefs*6), two
deletions (c.1560_1561del; p.Ser521Tyrfs*2 and
c.1771_1784del14; p.Asp591Phefs*9), and one splice-site
mutation (c.517+5G>C; p.Tyr126Hisfs*2). All were autosomal
dominant heterozygous mutations.
Reported DSG1 mutations causing SPPK are thought to result
in haploinsufficiency through nonsense-mediated mRNA decay.
In SAM syndrome, there is a near-total absence of DSG1 from the
cell membrane,9–11 as a result of either nonsense-mediated
mRNA decay,11 failure of DSG1 localization9 or decreased DSG1
expression.10 It therefore seems reasonable to hypothesize that













IIFig 4. Pedigree and mutation analysis of
families 6 (American) and case 7 (Ghanaian).
(a) Pedigree of family 6 showing a history of
palmoplantar keratoderma. The arrow
indicates the proband, who had a striate
digital pattern with diffuse keratoderma of the
soles. (b) DNA sequence of exon 12 of the
desmoglein 1 gene (DSG1) in an unaffected
control sample. (c) The same region of DSG1
from the proband of family 6, the arrow
indicates a novel mutation c.1771_1784del14,
resulting in p.Asp591Phefs*9. (d) Pedigree of
case 7. The arrow indicates the proband. (e)
Striate palmar hyperkeratosis (arrows) of the
proband in family 7. (f) Soles of the proband
showing diffuse hyperkeratosis. (g) Knuckle
pads over the proband’s dorsal interphalangeal
joints. (h) DNA sequence of exon 7 of DSG1
in an unaffected control sample. (i) The same
region as in (g) from the proband of family
7. The arrow indicates the heterozygous
mutation c.746dupT, resulting in
p.Met249Ilefs*6.
© 2016 The Authors. British Journal of Dermatology
published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
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SAM syndrome. Harmon et al. demonstrated that DSG1 interacts
with Erbin, downregulating the Ras/MAPK pathway. Elevated
Ras activity resulting from absent or insufficient DSG1 is postu-
lated as a mechanism underlying SPPK. The high rate of PPK in
disorders of the Ras/MAPK pathway supports this.12
DSG1 PPK phenotypes are restricted to areas of high pressure
and abrasion.3 Keratoderma can be exaggerated by environ-
mental factors, which may explain the striate pattern in the
soldier in family 2, when other family members had isolated
focal PPK. The mechanism for this is unclear, but may be a
result of reduced desmosome function,3,5 variations in desmo-
some configuration and protein expression,13 or a relative lack
of coping with/adapting to environmental stress in desmo-
glein-1 haploinsufficient individuals. Nonpalmoplantar hyperk-
eratotic plaques, as described in families 2 and 3, have been
reported in three other families with DSG1 mutations.7,14 The
proband in family 7 is the first reported case to have knuckle
and toe pads.
Our cases demonstrate phenotypic heterogeneity despite
their unifying molecular basis. Intrafamilial PPK variation has
been reported with DSG1 mutations,8,15,16 but the extent may
be underestimated. In family 1, only the proband had striate
palmar PPK; the two other affected relatives had no palmar
disease. In family 2, the proband had focal palmoplantar dis-
ease, and it was only when another relative presented with
striate palmar disease that DSG1 screening was performed,
which highlights the importance of examining multiple family
members. The recurrent mutation in families 2 and 3
(c.76C>T) has been reported in three other pedigrees – spo-
radic striate PPK,3 diffuse nonepidermolytic PPK,8 and striate
palmar and focal plantar keratoderma.17 DSG1 screening has
hitherto been performed primarily for striate PPK. Given the
variety of phenotypes, and the difficulty in distinguish-
ing these clinically, we suggest a low threshold for DSG1
screening in PPK where initial keratin gene screening has been
negative.
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